关注
Christopher J Schmoyer
Christopher J Schmoyer
Penn Presbyterian Medical Center
在 pennmedicine.upenn.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The pathogenesis and clinical management of stricturing Crohn disease
CJ Schmoyer, J Saidman, JL Bohl, CL Bierly, JF Kuemmerle, SJ Bickston
Inflammatory Bowel Diseases 27 (11), 1839-1852, 2021
212021
Diagnostic accuracy of noninvasive tests to detect advanced hepatic fibrosis in patients with hepatitis C and end-stage renal disease
CJ Schmoyer, D Kumar, G Gupta, RK Sterling
Clinical Gastroenterology and Hepatology 18 (10), 2332-2339. e1, 2020
162020
Tacrolimus‐Induced Type IV Renal Tubular Acidosis following Liver Transplantation
C Schmoyer, S Mishra, F Fulco
Case reports in hepatology 2017 (1), 9312481, 2017
72017
Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature
CJ Schmoyer, HD Brereton, EW Blomain
Oncology Letters 10 (1), 325-328, 2015
62015
Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home-vs Office-Based Biologic Infusions
CJ Schmoyer, K Sun, J Zack, P Kumar, R Shivashankar
Inflammatory Bowel Diseases 30 (9), 1529-1535, 2024
12024
Non-alcoholic Fatty Liver Disease in Non-obese Patients
CJ Schmoyer, MS Siddiqui
Current Hepatology Reports 16, 382-390, 2017
12017
Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease
H Kang, CJ Schmoyer, A Weiss, JD Lewis
Inflammatory Bowel Diseases, izae158, 2024
2024
Su1785 META-ANAYSIS OF THE THERAPEUTIC IMPACT OF CANNABIS AND CANNABINOID-DERIVATIVES IN INFLAMMATORY BOWEL DISEASE
H Kang, C Schmoyer, A Weiss, JD Lewis
Gastroenterology 166 (5), S-812, 2024
2024
Mo1883 EVALUATING AI-LANGUAGE MODELS IN PROVIDING ANSWERS FOR INFLAMMATORY BOWEL DISEASE (IBD) IN PREGNANCY: A COMPARATIVE ANALYSIS OF GPT4, BARD, AND LLAMA2
S Mukherjee, VCS Kumar, A Weiss, CJ Schmoyer, N Nandi
Gastroenterology 166 (5), S-1159, 2024
2024
S1015 Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home versus Office-Based Biologic Infusions
C Schmoyer, K Sun, J Zach, P Kumar, R Shivashankar
Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022
2022
The Safety of the Re-Opening of an Academic Medical Center Outpatient Endoscopy Unit During the COVID-19 Pandemic
S Manski, CJ Schmoyer, A Pang, J Lieberman, M Gernhardt, E Conn, ...
Gastroenterology Research 15 (4), 200, 2022
2022
Noninvasive Tests to Detect Advanced Fibrosis in Patients With Hepatitis C and End-Stage Renal Disease: Ready for Primetime? Reply
CJ Schmoyer, RK Sterling
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 19 (9), 1989-1990, 2021
2021
Diagnostic Accuracy of Noninvasive Tests to Detect Advanced Hepatic Fibrosis: Methodological Issues Reply
CJ Schmoyer, RK Sterling
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 19 (4), 857-857, 2021
2021
Sa1785 OPIOID USE IN IBD PATIENTS: INCREASED LENGTH OF STAY AND READMISSIONS AT 30, 60, AND 90-DAYS
J Saidman, C Schmoyer, JAH Roman, P Kakadiya, A Ulbing, C McHenry, ...
Gastroenterology 158 (6), S-422-S-423, 2020
2020
Diagnostic Accuracy of Non-Invasive Test of Hepatic Fibrosis in Liver Transplant Recipients.
D Galvez, C Bhati, M Siddiqui, C Schmoyer, T Arshad, A Sharma, ...
AMERICAN JOURNAL OF TRANSPLANTATION 18, 344-344, 2018
2018
Malignancy and Infectious-Related Mortality are Leading Causes of Long-Term Mortality in Patients Transplanted for Nonalcoholic Steatohepatitis
C Bhati, C Schmoyer, M Rivera, Y Shi, R Trevor, A Sharma, A Cotterell, ...
AMERICAN JOURNAL OF TRANSPLANTATION 17, 80-80, 2017
2017
Junctional adhesion molecule-A prevents cardiac rupture following myocardial infarction
C Schmoyer
University of Delaware, 2011
2011
系统目前无法执行此操作,请稍后再试。
文章 1–17